Lilly’s weight-loss pill wins FDA approval
For the first time, regulators have approved a small-molecule pill targeting glucagon-like peptide1 (GLP-1) for weight loss.…
Fiber supplement stabilizes blood sugar in gestational diabetes
A simple fiber supplement could reshape the gut microbiome, stabilize blood sugar spikes, and even prevent preterm births…
Modern lifestyle amplifies genetic risk for type 2 diabetes
Some people have a greater genetic risk than others of developing type 2 diabetes. Now, more of these…
Time-restricted eating improves hormone levels in women with PCOS
Polycystic ovary syndrome, or PCOS, affects as many as 18% of all childbearing-age women. The condition occurs when…
Obesity Beyond GLP-1s: Oral Formulations Take Center Stage – Citeline News & Insights
Obesity Beyond GLP-1s: Oral Formulations Take Center Stage Citeline News & InsightsUS weight-loss drugmakers slash prices in fight to…
Do GLP-1 Drugs Reduce Cancer Risk or Increase It?
IntroductionHow do GLP-1RAs work?The relationship between obesity and cancerWhat current research shows about GLP-1 drugs and cancer riskConflicting…
Hormonal contraception not associated with prevalence of idiopathic intracranial hypertension
Hormonal contraception, including birth control pills and intrauterine devices (IUDs), is not associated with an increased prevalence of…
New pathway enhances brown fat thermogenesis and metabolic health
Researchers have determined how a key protein activates brown fat by expanding blood vessels and nerves in the…
Wholegrain rye changes gut bacteria and lowers inflammation in obesity trial
A 12-week randomized trial found that wholegrain rye did not beat refined wheat for weight loss, but it…
Leaving home may worsen diet quality in young adults, Australian study finds
Moving out of the parental home may do more than change where young adults live; it may also…
Multiple sclerosis prevalence in England doubles due to better diagnosis
Multiple sclerosis (MS) has more than doubled in recorded prevalence in England from 2000 to 2020, increasing by…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…